AMY MARSHALL: Open Payments
NPI 1164825493 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 30 payments from 15 companies in 2025. Trend: 2023 $700 · 2024 $1,132 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $90 |
| Novo Nordisk Inc | 4 | $87 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| ABBVIE INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| Tonix Medicines, Inc. | 1 | $21 |
Products named: REXULTI, INGREZZA, Wegovy, FANAPT, AIRSUPRA, QULIPTA, NURTEC ODT, OTEZLA.
Industry payments across MI — which companies pay providers there.
